Ayushman Bharat can be a model to develop low cost healthcare systems in other parts of the world: GE Healthcare Industry-Economic Times — October 8, 2018 comments off As large Indian drug makers embark on their drive to manufacture biosimilar and complex vaccines, GE is hoping to ride on this next wave.
As large Indian drug makers embark on their drive to manufacture biosimilar and complex vaccines, GE is hoping to ride on this next wave.